October 2025
1. OSTRBENK A, Pedersen H, Poljak M, Bonde J, et al
   The Allplex HPV HR Detection assay fulfils international guideline requirements for primary cervical screening on SurePath samples and qualifies as a second-generation HPV comparator test.
   J Clin Virol. 2025;180:105853.
   

   >> Share

   
   August 2025
2. ARROYO MUHR LS, Eklund C, Lagheden C, Correa RM, et al
   The Human Papillomavirus (HPV) Laboratory e-Manual: A comprehensive guide for HPV testing and research.
   J Clin Virol. 2025;179:105834.
   

   >> Share

   
   December 2024
3. LATSUZBAIA A, Martinelli M, Giubbi C, Cuschieri K, et al
   Clinical accuracy of OncoPredict HPV Quantitative Typing (QT) assay on self-samples.
   J Clin Virol. 2024;175:105737.
   

   >> Share

   
   
4. FORSON W, Bhatia R, Currie H, Elasifer H, et al
   High-risk HPV mRNA testing on self-samples offered to those who do not attend for organised cervical screening - real world data from the Dumfries and Galloway region in Scotland.
   J Clin Virol. 2024;175:105734.
   

   >> Share

   
   June 2024
5. POLJAK M, Ostrbenk Valencak A, Cuschieri K, Bohinc KB, et al
   2023 global inventory of commercial molecular tests for human papillomaviruses (HPV).
   J Clin Virol. 2024;172:105671.
   

   >> Share

   
   April 2024
6. PRETET JL, Arroyo Muhr LS, Cuschieri K, Fellner MD, et al
   Human papillomavirus negative high grade cervical lesions and cancers: Suggested guidance for HPV testing quality assurance.
   J Clin Virol. 2024;171:105657.
   

   >> Share

   
   
7. HEIDEMAN DAM, Berkhof J, Verhoef L, Ouwerkerk C, et al
   Validation of the clinical performance and reproducibility of the NeuMoDx HPV assay self-sample workflow.
   J Clin Virol. 2024;171:105649.
   

   >> Share

   
   February 2024
8. YILMAZ E, Eklund C, Lagheden C, Robertsson KD, et al
   Corrigendum to "First international proficiency study on human papillomavirus testing in cervical cancer screening" [J Clin Virol. 2023 Oct;167:105581].
   J Clin Virol. 2024;171:105660.
   

   >> Share

   
   January 2024
9. OSTRBENK VALENCAK A, Cuschieri K, Connor L, Zore A, et al
   Allplex HPV HR Detection assay fulfils all clinical performance and reproducibility validation requirements for primary cervical cancer screening.
   J Clin Virol. 2024;170:105638.
   

   >> Share

   
   September 2023
10. YILMAZ E, Eklund C, Lagheden C, Robertsson KD, et al
    First international proficiency study on human papillomavirus testing in cervical cancer screening.
    J Clin Virol. 2023;167:105581.
    

    >> Share

    
    July 2023
11. ELASIFER H, Amukwaya MMN, Bhatia R, Cuschieri K, et al
    The role of circulating viral and tumour DNA in the diagnosis and management of HPV associated anogenital cancers, a systematic review and meta-analysis.
    J Clin Virol. 2023;164:105469.
    

    >> Share

    
    March 2023
12. MONTERO-MACIAS R, Veyer D, Bruneau T, Robillard N, et al
    TRANSLACOL project: Nodal human papillomavirus tumoral DNA detection by ddPCR for survival prediction in early cervical cancer patients without pelvic lymph node invasion.
    J Clin Virol. 2023;161:105418.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share